(CB) Chubb - Ratings and Ratios
Exchange: NYSE • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0044328745
CB EPS (Earnings per Share)
CB Revenue
CB: Insurance, Reinsurance, Commercial, Personal, Property
Chubb Ltd is a global insurance and reinsurance powerhouse, operating across six distinct business segments that cater to diverse customer needs. Its extensive product portfolio encompasses a wide range of insurance solutions, including commercial and personal lines, agricultural insurance, and reinsurance products, as well as life insurance and protection and savings products. The companys broad geographic footprint and diversified revenue streams enable it to navigate complex market dynamics and capitalize on emerging opportunities.
With a strong presence in the global insurance market, Chubb Ltd has established itself as a leading provider of specialized insurance products, including cyber insurance, environmental insurance, and political risk insurance. Its expertise in underwriting and risk management allows it to tailor insurance solutions to meet the unique needs of its clients, from individuals and small businesses to large corporations and agricultural enterprises. Chubbs product offerings also include various ancillary services, such as risk management and claims handling.
Analyzing the
Based on the available data, a forecast for Chubb Ltds stock performance can be constructed. Given the companys solid fundamentals, including a stable RoE and a reasonable P/E ratio, we can anticipate that the stock will continue to trade within a relatively narrow range in the short term. However, as the global insurance market continues to evolve and Chubb expands its product offerings and geographic reach, we expect the companys revenue and earnings to grow, potentially driving the stock price higher. A potential target price could be around $310, representing a 4.3% increase from the current price, assuming the company maintains its current momentum and continues to execute on its business strategy.
Additional Sources for CB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CB Stock Overview
Market Cap in USD | 120,197m |
Sector | Financial Services |
Industry | Insurance - Property & Casualty |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 1993-03-24 |
CB Stock Ratings
Growth Rating | 86.1 |
Fundamental | 66.5 |
Dividend Rating | 55.5 |
Rel. Strength | -9.93 |
Analysts | 3.59 of 5 |
Fair Price Momentum | 310.16 USD |
Fair Price DCF | 777.73 USD |
CB Dividends
Dividend Yield 12m | 1.31% |
Yield on Cost 5y | 3.13% |
Annual Growth 5y | 3.05% |
Payout Consistency | 96.7% |
Payout Ratio | 17.8% |
CB Growth Ratios
Growth Correlation 3m | -8.1% |
Growth Correlation 12m | 54.7% |
Growth Correlation 5y | 95.3% |
CAGR 5y | 19.35% |
CAGR/Max DD 5y | 1.00 |
Sharpe Ratio 12m | 0.98 |
Alpha | 4.62 |
Beta | 0.268 |
Volatility | 20.03% |
Current Volume | 964.6k |
Average Volume 20d | 1501.1k |
As of June 16, 2025, the stock is trading at USD 286.79 with a total of 964,649 shares traded.
Over the past week, the price has changed by -0.71%, over one month by -1.47%, over three months by -3.24% and over the past year by +11.44%.
Yes, based on ValueRay´s Fundamental Analyses, Chubb (NYSE:CB) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.47 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CB is around 310.16 USD . This means that CB is currently overvalued and has a potential downside of 8.15%.
Chubb has received a consensus analysts rating of 3.59. Therefor, it is recommend to hold CB.
- Strong Buy: 5
- Buy: 5
- Hold: 10
- Sell: 2
- Strong Sell: 0
According to our own proprietary Forecast Model, CB Chubb will be worth about 336.4 in June 2026. The stock is currently trading at 286.79. This means that the stock has a potential upside of +17.3%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 304.1 | 6% |
Analysts Target Price | 303.7 | 5.9% |
ValueRay Target Price | 336.4 | 17.3% |